2015-0407 - Consolidation - M Pharmaceutical Inc. (MQ)
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 04/16/15 -- M Pharmaceutical Inc. has announced the consolidation of its issued and outstanding share capital on the basis of one (1) post consolidation share for each ten (10) pre consolidation common shares. No fractional common shares will be issued pursuant to the consolidation, and any fractional common shares that would otherwise be issued will be rounded down or up to the nearest whole number.
As a result, the outstanding common shares of the company will be reduced to approximately 14,273,343
The shares will begin trading on a consolidated basis and with a new CUSIP number Friday, April 17, 2015.
The name and symbol will not change.
Please note that all open orders will be cancelled at the end of business today, April 16, 2015. Dealers are reminded to re-enter their orders taking into account the share consolidation.
Trading on a Consolidated Basis: April 17, 2015
NEW CUSIP: 55346E205
NEW ISIN: CA 55346E2050
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.04.2015 - 20:45 Uhr
Sprache: Deutsch
News-ID 386465
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Investment Services & Trading
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"2015-0407 - Consolidation - M Pharmaceutical Inc. (MQ)"
steht unter der journalistisch-redaktionellen Verantwortung von
Canadian Securities Exchange (CSE) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
